Zymeworks (ZYME) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
18 May, 2026Voting matters and shareholder proposals
Election of four directors: Kenneth Galbraith, Susan Mahony, Kelvin Neu, and Scott Platshon, with board recommendation to vote FOR all nominees.
Advisory vote on the compensation of named executive officers, with board recommendation to vote FOR.
Ratification of KPMG LLP as external auditors for the year ending December 31, 2024, with board recommendation to vote FOR.
Board of directors and corporate governance
Board recommends all director nominees for election at the annual meeting.
Shareholders can attend and vote at the meeting in person or by proxy, with detailed instructions provided.
Executive compensation and say-on-pay
Advisory vote on executive compensation is included as a key agenda item.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Zymeworks
- Annual meeting to vote on directors, executive pay, auditor, and highlight ESG and governance.ZYME
Proxy filing18 May 2026 - Board recommends approval of all proposals, with strong focus on governance and performance-based pay.ZYME
Proxy filing18 May 2026 - Q3 revenue up 73% on milestone and royalty gains, with narrowed net loss and strong cash runway.ZYME
Q3 202518 May 2026 - Virtual annual meeting on Dec 30, 2025, covers director elections, pay, and auditor ratification.ZYME
Proxy filing18 May 2026 - FDA Priority Review, $250M royalty loan, and robust pipeline drive long-term value.ZYME
Q1 202618 May 2026 - Robust pipeline advances and strong cash position drive a royalty-focused growth strategy.ZYME
The Citizens Life Sciences Conference 202615 May 2026 - Hybrid biotech-royalty model, strong pipeline, and $250M financing drive growth and flexibility.ZYME
TD Cowen 46th Annual Health Care Conference28 Apr 2026 - Strong financials and innovation drive growth, with key catalysts and pipeline advances ahead.ZYME
2026 Bloom Burton & Co. Healthcare Investor Conference21 Apr 2026 - Transitioning to a hybrid R&D and asset aggregation model, with strong cash and pipeline momentum.ZYME
25th Annual Needham Virtual Healthcare Conference15 Apr 2026